PLP1 anticorps (Middle Region)
Aperçu rapide pour PLP1 anticorps (Middle Region) (ABIN635575)
Antigène
Voir toutes PLP1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Specificité
- PLP1 antibody was raised against the middle region of PLP1
-
Purification
- Affinity purified
-
Immunogène
- PLP1 antibody was raised using the middle region of PLP1 corresponding to a region with amino acids IYGTASFFFLYGALLLAEGFYTTGAVRQIFGDYKTTICGKGLSATVTGGQ
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
PLP1 Blocking Peptide, (ABIN939605), is also available for use as a blocking control in assays to test for specificity of this PLP1 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of PLP1 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- PLP1 (Proteolipid Protein 1 (PLP1))
-
Autre désignation
- PLP1
-
Sujet
- PLP1 is a transmembrane proteolipid protein that is the predominant myelin protein present in the central nervous system. It may play a role in the compaction, stabilization, and maintenance of myelin sheaths, as well as in oligodendrocyte development and axonal survival. Mutations in this gene cause X-linked Pelizaeus-Merzbacher disease and spastic paraplegia type 2.
-
Poids moléculaire
- 30 kDa (MW of target protein)
Antigène
-